Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Epidemiologi for alkoholrelateret leversygdom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Skadelige konsekvenser af alkoholindtag blandt unge mennesker

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Rygning kan have skadelige effekter selv ved ophør før 30-årsalderen

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Behandling af indlæggelseskrævende COVID-19

    Research output: Contribution to journalReviewpeer-review

  5. Udredning og opfølgning af indlæggelseskrævende COVID-19

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Aspiration therapy with AspireAssist is a novel endoscopic
obesity treatment. Patients aspirate approximately 30% of
an ingested meal through a draining system connected to a
percutanous endoscopic gastrostomy tube. AspireAssist
was recently approved by the US Food and Drug Administration,
and it induces weight loss comparable to the
weight loss observed after bariatric surgery, but with a
lower risk of complications. Few clinical studies about the
efficacy and safety of AspireAssist have been carried out
and published. Thus, further intervention studies evaluating
acute as well as long-term effects are warranted.
Original languageDanish
JournalUgerskrift for Læger
ISSN0041-5782
Publication statusPublished - 7 Aug 2017

ID: 53674440